People living with aortic stenosis (AS) could gain earlier access to innovative care and treatment thanks to a new effort ...

People living with aortic stenosis (AS) could gain earlier access to innovative care and treatment thanks to a new effort ...

clinical trial which is designed to evaluate the DurAVR Transcatheter Heart Valve, THV, in patients with severe calcific aortic stenosis and to support a future PMA submission. “We are extremely ...

PARADIGM: A Prospective rAndomized tRial Assessing the safety and effectiveness of the DurAVR® bIomimetic valve designed for physioloGic flow compared to CoMmercial TAVR devices MINNEAPOLIS and ...

Anteris Technologies has won FDA approval to conduct a key clinical trial for its heart valve device in the US.

The Central Chest Institute of Thailand (CCIT) in Nonthaburi has adopted the Tavi procedure to treat aortic valve stenosis, a ...

Trials from Edwards, Philips and Penumbra were among the most-watched studies at the annual cardiovascular meeting.

Edwards Lifesciences has raised its fiscal year (FY25) guidance to between $2.56 to $2.62 per share after achieving better ...

A troubling rise in severe diverticulitis cases among Americans under 50 highlights a significant public health concern.

Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company, ...

Anteris Technologies (Nasdaq:AVR) today announced one-year clinical outcomes for its DurAVR transcatheter heart valve (THV).